Get started
Author

Н. С. Руднева

Observed names: N. Rudneva, N. S Rudneva, N. S. Rudneva, N. S. Rudnevа, N.S. Rudneva, N.S. Rudneva Rudneva, Natal'ya Rudneva, Natalia Rudneva, Natalia S. Rudneva, Natalya S. Rudneva, Н С Руднева
ORCID: 0000-0001-9638-2290
Observed ORCIDs: 0000-0001-9638-2290, 0000-0002-0621-5518
OpenAlex ID: A5012829095
Prevalence of macrolide and fluoroquinolone resistance-mediating mutations in Mycoplasma genitalium in five cities in Russia and Estonia
2017 · Elena Shipitsyna, Tatiana Rumyantseva, et al. · PLoS ONE · 47
PDF
Inverse psoriasis and psoriasis of ‘difficult’ localizations: Effectiveness of netakimab
2022 · L. S. Kruglova, N. S. Rudneva, et al. · Medical alphabet · 10
Efficacy and safety of dupilumab in complex treatment of patients with severe atopic dermatitis
2021 · L. S. Kruglova, Е. А. Shatohina, et al. · Medical alphabet · 5
Monitoring of macrolide resistanceassociated mutations in Mycoplasma genitalium in Russia
2022 · I.A. Edelstein, N.S. Rudneva, et al. · Clinical Microbiology and Antimicrobial Chemotherapy · 4
PDF
The Aexperience of the Organization and the Screening of Pregnant Women for the Purpose of Detecting Sexually Transmitted Infections, in the Framework of the Regional Program of the Tula Region
2015 · Анисимова, N. Anisimova, et al. · Journal of New Medical Technologies · 4
Efficacy and safety of netakimab therapy in patients with moderate to severe psoriasis in real clinical practice
2023 · Andrey L. Bakulev, Olga A. Pritulo, et al. · Vestnik dermatologii i venerologii · 3
PDF
The rates of mutations associated with macrolide resistance in Mycoplasma genitalium among patients with non-gonococcal sexually transmitted infections in Smolensk and Tula
2019 · L.M. Zubareva, Inna A. Edelstein, et al. · Clinical Microbiology and Antimicrobial Chemotherapy · 3
PDF
Regional adaptation of the federal model of reimbursement for medical assistance based on clinical statistical groups: hospitalization of patients in need of genetically enginered biological preparations
2018 · M. V. Sura, T. N. Ignatova, et al. · FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology · 3
PDF
Macrolide and fluoroquinolone resistance in Mycoplasma genitalium isolated from pregnant women in Russia and Belarus
2024 · D.A. Avchinnikova, I.A. Edelstein, et al. · Clinical Microbiology and Antimicrobial Chemotherapy · 2
PDF
Issues of use of hepatoprotectors in psoriasis: Indications and effectiveness
2022 · L. S. Kruglova, N. S. Rudneva, et al. · Medical alphabet · 2
Certolizumab pegol: new opportunities for treatment of moderate to severe plaque psoriasis
2019 · A. A. Kubanov, A. L. Bakulev, et al. · Vestnik dermatologii i venerologii · 2
PDF
Early administration of genetically engineered biological agents as effective secondary prevention of psoriatic arthritis
2025 · N. O. Pereverzina, L. S. Kruglova, et al. · Medical alphabet · 1
PDF
Modern Clinical and Epidemiological Features of Psoriasis
2025 · S.K. Sarsur, N.S. Rudneva · Современные проблемы науки и образования · 1
PDF
Pustular psoriasis treated with IL-17a antibody secukinumab
2022 · N. S. Rudneva, E. V. Natarova, et al. · Medical alphabet · 1
Case of bullous pemphigoid in patient with psoriasis, after new coronavirus infection COVID‑19
2021 · N. S. Rudneva, T. G. Sadunashvili, et al. · Medical alphabet · 1
PDF
Hematidrosis or artistic dermatitis?
2020 · V. N. Karpukhina, N. S. Rudneva, et al. · Medical alphabet · 1
PDF
Certolizumab pegol for treatment of severe plaque psoriasis: local experience
2019 · N. S. Rudneva, T. G. Sadunashvili, et al. · Medical alphabet · 1
PDF
Rare Forms of Exanthems in Pediatric Clinical Practice
2018 · V. S. Sobolenkova, S. Yu. Fedorov, et al. · CHILDREN INFECTIONS · 1
PDF
Russian interdisciplinary consensus on the definitions of “difficult-to-manage” and “difficult-to-treat” psoriatic arthritis/psoriasis and the management of these patients
2026 · A. M Lila, T. V. Korotaeva, et al. · Modern Rheumatology Journal
PDF
Russian interdisciplinary consensus on the definition of “Complex to manage” and “Difficult to treat” psoriatic arthritis/psoriasis and the management of these patients. Positions of dermatovenerologists
2026 · L. S. Kruglova, A. L. Bakulev, et al. · Medical alphabet
PDF
Cytokine profile and predictors of the efficacy of genetically engineered biological therapy for psoriasis and psoriatic arthritis: a literature review
2026 · S. R. Redko, N. S. Rudneva · Medical alphabet
PDF
Results of CRYSTAL retrospective observational study in Russia: severity of the disease, treatment landscapes and quality of life in patients with moderate to severe psoriasis receiving systemic therapy in routine clinical practice
2025 · Muza M. Kokhan, Natalia S. Rudneva, et al. · Vestnik dermatologii i venerologii
PDF
Risk Analysis and Adverse Events of Tnf-α and Il-17a Inhibitors in Psoriasis
2025 · S.K. Sarsur, N.S. Rudneva · Современные проблемы науки и образования
PDF
Efficacy of netakimab in patients with psoriasis and disease duration up to 1 year: implementation of a strategy for early prescription of genetic engineering biological therapy
2024 · L. S. Kruglova, N. O. Pereverzina, et al. · Medical alphabet
PDF
Results of comparison of the effectiveness of adalimumab and ixekizumab in the treatment of psoriasis
2023 · Sh.Kh.R. Sarsur Sarsur, N.S. Rudneva Rudneva · Фарматека
Works count: 40
Citation count: 92
H-index: 4
I10-index: 2
Year
Topic
Type